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Issue Brief: Provider Perspectives

Challenges & Strategies to Expanding MAT within Primary Care
Rachel Gallo, MPH; Mary Lindsey Smith, PhD, MSW; and Katie Rosingana, BA
University of Southern Maine, Muskie School of Public Service

INTRODUCTION

Medication-Assisted Treatment (MAT) in primary

The high rate of opioid misuse and subsequent

Maine were selected in 2017 to plan and implement

health crisis. Despite numerous statewide efforts to

workflows, and networks. While each grantee

care settings. Ten grantee projects throughout

addiction is an ongoing national and local public

the integration of MAT into health system practices,

reduce rates of opioid prescribing, prevent diversion,

organization has specific strategies aimed at

disorder (OUD), rates of opioid-related overdoses

the overarching goal of the Addiction Care Program

Program focuses on addressing opioid-related

primary care for people with OUD.

and increase access to treatment for opioid use

and deaths remain high. MeHAF’s Addiction Care

addressing the unique needs of their community,

is to create new or expand capacity for MAT in

morbidity and mortality by supporting capacity
building efforts to increase

Medication-Assisted Treatment (MAT)
What is MAT?

MAT is an evidence-based path of recovery from substance use disorders (SUD) facilitated by medically
monitored pharmacological agents approved by the FDA. For opioid use disorder (OUD), these medications
include methadone, naltrexone, and buprenorphine (common brand names: Suboxone and Subutex). MAT is
the combination of behavioral therapy with medication that is effective for many, but not all individuals.

Who can provide MAT?

In Maine, physicians (MD, DO), nurse practitioners (NP), and physician assistants (PA) can prescribe the
medication(s) associated with MAT for opioid use disorder. To prescribe buprenorphine, providers must take
additional training and receive a waiver from the federal government (X-waiver). The provider works
collaboratively with the patient and with behavioral health professionals to provide comprehensive care for the
person receiving MAT.

What type of training is required to provide MAT?

Physicians are required to complete an eight-hour training to qualify for an X-waiver to prescribe and dispense
buprenorphine. Nurse practitioners and physician assistants are required to complete 24 hours of training,
including the initial eight-hour MAT training for physicians.

Who is a good candidate for MAT?

Per guidance from the U.S. Substance Abuse and Mental Health Services Agency (SAMHSA), a good candidate
for MAT for opioid use disorder:
•
Has an official diagnosis of an opioid use disorder.
•
Is willing to fully comply with prescribing instructions.
•
Lacks physical health issues that the medication could possibly exacerbate.
•
Is fully educated on alternative options.
For more information on MAT: https://www.samhsa.gov/medication-assisted-treatment

DATA COLLECTION
The Muskie School of Public Service at the University
of Southern Maine (Muskie) was contracted by
MeHAF to conduct an independent evaluation of the
implementation and effectiveness of the Addiction
Care Program. As a part of the evaluation, data was
collected from participating Addiction Care Program
sites between May of 2017 and May of 2019 via
provider focus groups and surveys as well as
programmatic data dashboards.
Providers: Prescribers and anyone
with direct interactions with MAT
participants/patients. This staff
includes but is not limited to:
MD/DOs, PAs, RNs, LPNs,
CMA/MAs, managers, LCSWs, and
other behavioral health staff.
Focus groups were conducted using a semistructured protocol in the last two quarters of Year
One (N=36) and in Year Two (N=66). The focus
groups in Year Two not only included providers, but
also members of change teams. Change teams are
comprised of individuals who are involved in the dayto-day collaborative and operational aspects of
project implementation. Each grantee project has a
change team specific to the work of the Addiction
Care Program. Providers on change teams are
dedicated champions working towards the
implementation of MAT within their primary care
setting.
All focus groups were recorded and
transcribed verbatim for analysis. Qualitative data
analysis was done iteratively to identify reoccurring
themes.
Surveys were deployed to providers at the beginning
of Year One (N=92) and at the end of Year Two
(N=31). Quantitative survey data were analyzed
using appropriate descriptive statistics such as means
and frequencies.
Data dashboards were created in Microsoft Excel for
each grantee to record de-identified continuous

quality improvement data (ie. number of individuals
screened for OUD, number of individuals receiving
MAT) and administrative data including: education
and training sessions, stakeholder engagement, and
individualized grantee-specific data. This issue brief
provides a summary of provider perspectives
obtained via these three data collection methods.

PROVIDER-IDENTIFIED CHALLENGES
Organizational Supports
Providers working within grantee organizations
frequently mentioned the need for resources to
support their MAT implementation and expansion
efforts. Internally, the key organizational supports
identified by providers that are necessary to support
the provision of MAT in primary care settings include:
support for personnel at all levels; support and
resources for prescribers (i.e. opportunities for peerto-peer mentoring); communication infrastructure
within and across organizations to support
comprehensive integrated care; and stakeholder
engagement, particularly of individuals with OUD to
inform program policies and procedures. Providers
indicated that they are reluctant to deliver MAT if
they do not feel they have these necessary
organizational supports. One focus group participant
stated that, “The practice has to be ready right from
the receptionist. It’s a whole team. It’s a pretty
massive undertaking and a cultural shift.” Grantees
continue to use various strategies to strengthen
organizational support and ensure practices are wellprepared for successfully delivering MAT (See table
on next page).
Organizational cultures shifted as grantees
implemented MAT, completed more MAT-related
training, and included stakeholders in the process.
One focus group participant stated at the end of Year
Two, “People were scared of it [implementing
MAT]. They didn't know what was going to
happen. [It’s] really just blossomed and it’s really
been a beautiful transition.”
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By setting up supports for prescribers, including the
(sometimes called a Universal Agreement) which
infrastructure for communication, providers became
allows for shared patient information between
more confident in their organization’s ability to
primary care physicians, specialists, and behavioral
health staff.
integrate MAT into clinical work with patients. One
survey question asked, “On a scale of 1 to 10, where
Figure 1. My colleagues have had success in
1 is “not confident” and 10 is “extremely confident,”
dealing with OUD-related problems.
(provider survey, all respondents)
how confident are you in your organization’s ability
to integrate MAT into clinical work with patients?” The
pre
18%
38%
44%
mean score for this question significantly increased
post 3%10%
86%
from 6.8 in the first year to 8.3 in the second year.
One driver of this shift was the incorporation of data
Strongly Disagree/Disagree
Neutral
Agree/Strongly Agree
sharing agreements
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Additionally, providers in the second year were
significantly less likely to say they experienced
conflicts in their decision on whether or not to
address OUD in their practice and also felt their
colleagues were having more success in dealing with
OUD-related problems (Figure 1).

organizations (Figure 2). In the same time frame,
grantee organizations were able to increase the
number of patients in their MAT programs. Data
collected via the data dashboards shows grantees
collectively enrolled twelve times as many patients in
their MAT programs at the end of the second year
compared to the start of the first year.

Workforce
The ability of organizations to expand access to MAT
is constrained by workforce shortages and staff
turnover. During the first year of the program,
providers frequently mentioned that their ability to
provide services to address OUD in their
communities was significantly impacted by the lack
of waivered providers and behavioral health
counselors. Moreover, providers indicated that the
lack of available and trained staff to help with
scheduling and managing care coordination for MAT
patients often forced them to limit the size of their
MAT patient panel.
In order to address the workforce capacity issues
identified by providers, grantee organizations
leveraged resources provided by the Addiction Care
Program to employ additional staff. These employees
support care integration, patient navigation, and
connections to community supports.
“I feel some of our greatest success has
been the continuous addition of
providers to our team.”

-Provider, Year Two

Additionally, education and training sessions on
numerous topics, including the federal X-waiver
training required to deliver MAT, as well as trainings
for specific roles and workflows, led to increased
capacity for grantees to deliver MAT. Ongoing MAT
trainings ultimately increased the number of
prescribers from 48 at the start of the program to 136
by the end of the second year of the Addiction Care
Program, representing a nearly three-fold increase in
the number of providers delivering MAT at grantee

Figure 2. Total Number of Prescribers
Delivering MAT by Month
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Payment and Reimbursement for Services
In the first year of the Addiction Care Program,
providers indicated that reimbursement for services
was the number one barrier to expanding access to
MAT. Individuals with private or public insurance face
cost barriers as many insurance companies do not
fully cover or pay for the costs of patients’
buprenorphine prescriptions and their treatment.
Some insurance companies have placed limits and
regulations on who can be prescribed MAT and for
what duration. Practices lacked the necessary
financial resources to implement and/or expand MAT
programs
without
external
funding
(e.g.
reimbursement for supportive services and funding
for training).
The expansion of MaineCare, Maine’s Medicaid
program, will address some of these financial barriers.
MaineCare expansion is expected to lead to increased
coverage of low-income adults who have SUD. The
expansion has already led to increased
Page | 4

reimbursement rates for treatment and support
services. 1 Currently, some practices are striving to
overcome this barrier by working to meet the
eligibility requirements for Maine’s Opioid Health
Home programs, which are specifically designed to
provide financial resources to support MAT and care
coordination for complex uninsured and underinsured patients.

Training and Education
Providers regularly mentioned the lack of proper
training and education for both providers and staff as
barriers to expanding access to MAT. Respondents
expressed the need for trainings for a variety of
providers including, but not limited to: prescribers,
nurses, social workers, therapists, counselors, and peer
recovery coaches. Additionally, providers noted that
current and future MAT prescribers could benefit from
professional mentoring, especially for providers that
have newly completed the federal X-waiver training
required to deliver MAT. Most providers agreed that a
more formal MAT provider-to-provider network within
their own system and/ or perhaps a statewide
clearinghouse would be beneficial for further training,
consultation, and information sharing.
Throughout the grant period, grantee organizations
made significant investments in training and
education. By the end of the second year of the
program, 116 healthcare staff completed trainings
focused on MAT, and an additional 558
training/education sessions were conducted by
grantee sites. 2 The most frequent training and
education topics are shown in Figure 3. Grantee
organizations have also focused on supporting
providers by setting up opportunities for and
encouraging peer-to-peer support. As a provider
within a large health system explained, “A lot of the
education has been provider to provider, which
makes a big difference. Speaking to a colleague is
very different than sitting in a meeting. One of

Clemans-Cope, Lisa, et al. The Urban Institute. Leveraging Medicaid
to Address Opioid and Substance Use Disorders in Maine: Ten State
Policy
Options
from
an
Expedited
Review.
2019,
1

our walk-in care providers has started doing MAT
and does a fabulous job. Now the other walk-in
care providers are starting to ask questions and
are interested in it. So seeing people do it, more
providers are like ‘I can do that.’ It makes sense.”

Treatment Program Policies
Figure 3.

Most Frequent Training and Education Topics
Reducing Stigma
Community Organizing
X Waiver Training
Workflow Implementation
Peer Sharing
Prevention
Diagnosing and Treating…
Grant Related
Hub and Spoke Model
Recovery / Peer Recovery
Addiction/ OUDs / Opioids

23
23
27
29
30
32

43
51
52
54
58

During the first year of the Addiction Care Program,
providers frequently reported that inflexible MAT
program policies as well as external policies, such as
insurers’ cumbersome prior authorization processes
and barriers around sharing protected health
information, made it difficult to have continuity of
care in treatment and recovery. Inflexible program
policies were often cited as impediments to
successful treatment and often “set patients up for
failure” by penalizing patients if they missed an
appointment or group therapy session, experienced
a reoccurrence, or had a change in insurance.
Providers’ concerns were echoed by program
participants who indicated that while they
appreciated the accountability the MAT programs
were offering, they felt that the treatment programs
could benefit from more flexibility to “meet the
patient where they are.”

www.urban.org/sites/default/files/publication/100443/2019.06.20_
mainecare_report_final_7.pdf.
2 Training and Education sessions recorded in grantees’ data
dashboards in the first two years of the grant.
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In an effort to provide more patient-centered care
and promote long-term patient engagement in
treatment
and
recovery
services,
grantee
organizations devoted resources in the second year
of the Addiction Care Program to developing policies
and procedures that offer greater flexibility to
participants. For example, several grantee
organizations responded to feedback from providers
and patients by adjusting some of the stringent
Intensive Outpatient (IOP) requirements (i.e.
attending IOP 3-4 hours a day, 5 days a week) that
were part of their first phase of the MAT program. In
some cases, grantees reduced the length of time
needed to complete IOP, or adjusted the number of
group sessions needed to remain enrolled in the IOP.

“I think meeting patients where they're
at when they come into our services is

In addition, during the second year of the Addiction
Care Program, grantee organizations offered more
therapeutic options by varying group therapy
sessions by size, time, and/or gender, and in some
cases allowed patients who were unable to attend
group therapy in a certain week the option to check
in one-on-one with their prescriber or group leader.
Ensuring treatment program policies are adaptive
and flexible leads to greater continuity of care.

Stigma
Throughout the grant, providers reported that stigma
among medical providers and staff often underlies or
compounds the challenges associated with many of
the barriers to MAT expansion. Stigma related to
perceived work burden, around MAT treatment in
primary care, and the nature of OUD as a disease
contributes to a lack of providers willing to prescribe
medications for OUD treatment.

critically important because there’s a lot
of places that just say ‘oh, you're new to
treatment, you need an IOP,’ which
discourages patients from entering
treatment because they may be like ‘I'm
not going to quit my job. I need
Suboxone but I'm not going to quit my

“One of the most challenging

things I've learned about is the
strength of the stigma. I don't

even mean on the streets or the

neighborhood, I mean here [within
the health organization].”

-Provider, Year Two

job’ or whatever the situation is, or ‘I
can't get there five days a week.’ So the
fact is that we’re here to help you and
we’re here to meet whatever your
individual needs are, it’s not a one-sizefits-all operation. It’s a continuum of
care, which I think should be the model
that people are striving toward.”
-Provider, Year Two

To address stigma at the provider level, grantees
focused on utilizing educational opportunities as a
mechanism to reduce stigma related to OUDs,
offering trainings on stigma reduction for all
providers, not just prescribers, as well as office staff.
Over the course of the grant, 23 “reducing stigma”
educational sessions took place. 3
Additionally, prescribers discussed the importance
of behavior modeling for other providers and coworkers. Grantee organizations have made a
conscious effort to continually discuss mechanisms
to address and reduce stigma through regular

Training and education sessions recorded in grantees’ data
dashboards in the first two years of the grant.
3
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SUMMARY

conversations at project or staff meetings and by
providing both organizational and peer support
aimed at reducing stigma within the health care
system.

Grantees have made great progress integrating MAT

By the end of the second year of the Addiction Care

networks.

Program, survey results indicated that providers who

were certified to prescribe were significantly more
likely to feel that OUD-related problems were given

equal priority as other chronic conditions within their

organization. This indicates a shift in provider-based
stigma and a change in organizational readiness to
incorporate and address MAT within their practices.

One provider stated, “I think differently now about

my recovery patients and how I deal with them
than I did when we started a year and a half, two

years ago. I have different expectations of them
and myself in the way I treat them.”

organizations, Addiction Care Program grantees have
the

comprehensive

health

system

While

practices,

challenges

workflows,

have

been

and

met

throughout this process, grantees have been

strategic in alleviating internal and external resource
barriers (i.e. organizational supports, workforce,

payment and reimbursement), providing training and
educational
program

opportunities,

policies

are

ensuring

treatment

patient-centered,

and

addressing stigma. As a result of these efforts,

primary care practices are undergoing organizational
shifts. Resources from the Addiction Care Program
have enabled grantees to address challenges they
met at the beginning of the grant, subsequently

ensuring more individuals with OUD are able to

In addition to working on reducing stigma within their
leveraged

into

cross-sector

partnerships they have built between health care, first
responders, law enforcement, business, peer recovery

and social service agencies to provide education and

access treatment. The strategies utilized by grantee

organizations as part of the Addiction Care Program

are addressing crucial access gaps in treatment
infrastructure,

provider

training/education,

and

organizational capacity to deliver MAT in primary
care settings.

training across these stakeholder groups aimed at

changing individuals’ beliefs and attitudes about OUD

and the use of MAT to address OUD. Promoting

“My dream is someday that opioid use

stigma reduction among community partners is

disorder will be actually seen the same as

building the infrastructure necessary to creating

will come.”

critical to fostering clinical-community linkages and
sustainable community systems of care for individuals
in treatment and recovery.

COPD, diabetes, hypertension. I think it

-Provider, Year One
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